Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold-Reference-Cited by-同舟云学术

Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold

Published:2010-10-13 Issue:6 Volume:27 Page:859-866
ISSN:1569-5794
Container-title:The International Journal of Cardiovascular Imaging
language:en
Short-container-title:Int J Cardiovasc Imaging

Author:

Brugaletta Salvatore,Garcia-Garcia Hector M.,Garg Scot,Gomez-Lara Josep,Diletti Roberto,Onuma Yoshinobu,van Geuns Robert Jan,McClean Dougal,Dudek Dariusz,Thuesen Leif,Chevalier Bernard,Windecker Stephan,Whitbourn Robert,Dorange Cecile,Miquel-Hebert Karine,Sudhir Krishnankutty,Ormiston John A.,Serruys Patrick W.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s10554-010-9724-y.pdf

Reference25 articles.

1. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349(14):1315–1323. doi: 10.1056/NEJMoa035071349/14/1315[pii]

2. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R (2007) Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27(7):1500–1510. doi: ATVBAHA.107.144220[pii]10.1161/ATVBAHA.107.144220

3. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48(1):193–202. doi: S0735-1097(06)01109-0[pii]10.1016/j.jacc.2006.03.042

4. Wilson GJ, Nakazawa G, Schwartz RS, Huibregtse B, Poff B, Herbst TJ, Baim DS, Virmani R (2009) Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Circulation 120(2):141–149, 141–142. doi:CIRCULATIONAHA.107.730010 [pii] 10.1161/CIRCULATIONAHA.107.730010

5. Kim SW, Mintz GS, Hong YJ, Pakala R, Park KS, Pichard AD, Satler LF, Kent KM, Suddath WO, Waksman R, Weissman NJ (2008) The virtual histology intravascular ultrasound appearance of newly placed drug-eluting stents. Am J Cardiol 102(9):1182–1186. doi: S0002-9149(08)00567-5[pii]10.1016/j.amjcard.2008.03.054

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronary bioresorbable stents: Non-invasive quantitative evaluation of intra- and juxta-stent plaque composition—A computed tomography longitudinal study;PLOS ONE;2022-10-13

2. Undiscovered pathology of transient scaffolding remains a driver of failures in clinical trials;World Journal of Cardiology;2018-10-26

3. Serial Assessment of Tissue Precursors and Progression of Coronary Calcification Analyzed by Fusion of IVUS and OCT;JACC: Cardiovascular Imaging;2017-10

4. Imaging assessment of bioresorbable vascular scaffolds;Cardiovascular Intervention and Therapeutics;2017-08-01

5. WITHDRAWN: What exactly, regression of atherosclerosis or foreign body reaction with hyaline arteriosclerosis, drives transient scaffolding of coronary arteries? A pooled analysis of observational ABSORB studies with a serial multimodality imaging substudy of ABSORB cohort B1 trial;International Journal of Cardiology;2017-06